The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. (Q51816348)

13 April 2018

title

The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. (English)

1 reference

13 April 2018

primary mediastinal B-cell lymphoma

main subject

1 reference

Mohamed E Salama

1

1 reference

13 April 2018

M Rajan Mariappan

2

1 reference

13 April 2018

Kedar Inamdar

3

1 reference

13 April 2018

Sheryl R Tripp

4

1 reference

13 April 2018

Sherrie L Perkins

5

1 reference

13 April 2018

publication date

17 February 2009

1 reference

13 April 2018

International Journal of Surgical Pathology

published in

1 reference

13 April 2018

volume

18

1 reference

13 April 2018

issue

2

1 reference

13 April 2018

page(s)

121-128

1 reference

13 April 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Part II: Hodgkin's lymphoma--diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

The human thymus contains a novel population of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1066896909331994

21 January 2018

Identifiers

DOI

10.1177/1066896909331994

1 reference

13 April 2018

release_uq5d5aggvrg4rfvjxpn7dyl7em

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uq5d5aggvrg4rfvjxpn7dyl7em

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 April 2018